Article
Mediator subunit MED1 differentially modulates mutant thyroid hormone receptor intracellular dynamics in Resistance to Thyroid Hormone syndrome.
Molecular and cellular endocrinology - 1 Jan 2023
Wang Moyao, Roggero Vincent R, Allison Lizabeth A
Abstract excerpt
Thyroid hormone receptor (TR) controls the expression of thyroid hormone (T3)-responsive genes, while undergoing rapid nucleocytoplasmic shuttling. In Resistance to Thyroid Hormone syndrome (RTH), mutant TR fails to activate T3-dependent transcription. Previously, we showed that Mediator subunit 1 (MED1) plays a role in TR nuclear retention. Here, we investigated MED1's effect on RTH mutants using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
